$19.90
-4.5%Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.
Executive Vice President & President of Asia/Pacific (APAC)
Compensation
$670,212
Executive Vice President & President of North America
Executive Vice President and President of Europe & Latin America
Compensation
$496,146
Executive Vice President of Finance, Chief Financial Officer & Treasurer
Compensation
$668,516
Executive Vice President of Global Supply Chain Operations
Compensation
$690,725
Executive Vice President, General Counsel & Secretary
Global Chief Marketing Officer
President, Chief Executive Officer & Director
Compensation
$1,400,526
Senior Vice President of Global Human Resources
Vice President of Global Impact & Sustainability
During the last 12 months, insiders have sold $35.05M worth of NATR shares, with no buying activity reported.
0
0.00
50.9K
1.21M
-1.2M
-$1.21M
0
0.00
1.7K
37.89K
-38K
-$38K
0
0.00
18.9K
383.13K
-383K
-$383K
0
0.00
2.9M
33.41M
-33.4M
-$33.41M
No buying activity
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
10 Percent Owner
$32.71M
Yates Bryant J
Officer: Evp & President, Europe
$701K
Norman Daniel C
Officer: Evp & President, Asia
$584K
Brower Nathan G
Officer: Evp, General Counsel
$529K
Lanoy Jonathan David
Officer: Svp, Chief Accounting Officer
$289K
Strong bearish signal with $35.05M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
NATR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 27, 2026 | March 27, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 20, 2025 | March 20, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 15, 2024 | May 01, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | March 24, 2023 | March 24, 2023 | 2023 | |
DEF 14A DEF 14A 2021 N/A | March 18, 2022 | December 31, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 19, 2021 | December 31, 2020 | 2020 | |
DEF 14A DEF 14A 2020 N/A | March 27, 2020 | May 06, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 22, 2019 | May 08, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 26, 2018 | May 02, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 24, 2017 | May 09, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.